Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

TED-347

Copy Product Info
🥰Excellent
Catalog No. T8421Cas No. 2378626-29-8

TED-347 is an irreversible and covalent inhibitor of TEAD4-Yap1 protein-protein interaction(EC50 of 5.9 μM), and inhibits glioblastoma cell viability.

TED-347

TED-347

Copy Product Info
🥰Excellent
Purity: 99.9%
Catalog No. T8421Cas No. 2378626-29-8
TED-347 is an irreversible and covalent inhibitor of TEAD4-Yap1 protein-protein interaction(EC50 of 5.9 μM), and inhibits glioblastoma cell viability.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$78In StockIn Stock
5 mg$116In StockIn Stock
10 mg$163In StockIn Stock
25 mg$328In StockIn Stock
50 mg$496In StockIn Stock
100 mg$712In StockIn Stock
1 mL x 10 mM (in DMSO)$98In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.9%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

TED-347 AI Summary
TED-347 exhibits significant bioactivity by inhibiting various protein interactions. It inhibits the binding of CPM to N-terminal His6-tagged human TEAD4 with an IC50 of 800.0 nM and shows a Ki value of 10400.0 nM for this interaction. Additionally, the compound demonstrates an IC50 of 14100.0 nM for binding to FITC-labeled palmitate tracer. TED-347 also inhibits the interaction between TEAD4 and Yap1, with an EC50 of 5900.0 nM after 24 hours as measured by a fluorescence polarization assay. These properties suggest potential therapeutic applications for TED-347 as an inhibitor in these protein interactions and tracer bindings..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
TED-347 is an irreversible and covalent inhibitor of TEAD4-Yap1 protein-protein interaction(EC50 of 5.9 μM), and inhibits glioblastoma cell viability.
Targets&IC50
TEAD4-Yap1:5.9 μM(EC50)
Chemical Properties
Molecular Weight313.7
FormulaC15H11ClF3NO
Cas No.2378626-29-8
SmilesFC(F)(F)c1cccc(Nc2ccccc2C(=O)CCl)c1
Relative Density.1.352 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 250 mg/mL (796.94 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+90% Corn Oil: 5 mg/mL (15.94 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.1878 mL15.9388 mL31.8776 mL159.3880 mL
5 mM0.6376 mL3.1878 mL6.3755 mL31.8776 mL
10 mM0.3188 mL1.5939 mL3.1878 mL15.9388 mL
20 mM0.1594 mL0.7969 mL1.5939 mL7.9694 mL
50 mM0.0638 mL0.3188 mL0.6376 mL3.1878 mL
100 mM0.0319 mL0.1594 mL0.3188 mL1.5939 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy TED-347 | purchase TED-347 | TED-347 cost | order TED-347 | TED-347 chemical structure | TED-347 formula | TED-347 molecular weight